GADD45B and hepatocellular carcinoma: Exogenous SAM administration inhibits DNA synthesis in hepatocytes and HCC cells by several mechanisms including blockage of the HGF-mediated activation of LKB1/AMPK signaling [40], restoration of the DNA methylation level [41] and induction of the GADD45β expression [21, 22].